Lead Exposure and Prevention Advisory Committee (LEPAC); Correction, 70630 [2020-24507]
Download as PDF
<![CDATA[
70630
Federal Register / Vol. 85, No. 215 / Thursday, November 5, 2020 / Notices
statement, may request it at the time of
the public comment period on
December 9, 2020 at 11:55 a.m., EST.
Written Public Comment: The public
is welcome to submit written comments
in advance of the meeting. Comments
should be submitted in writing
according to the instructions provided.
The deadline for receipt of written
public comment is December 6, 2020,
EST. All requests must contain the
name, address, and organizational
affiliation of the speaker, as well as the
topic being addressed. Written
comments received in advance of the
meeting will be included in the official
record of the meeting.
Matters to be Considered: The agenda
will include discussions and updates
on: (1) TBTC Study 31: Rifapentinecontaining Tuberculosis Treatment
Shortening Regimens; (2) Latent
Tuberculosis Infection (LTBI)
Community Engagement; (3)
Bedaquiline + Pretomanid + Linezolid
(BPal) Clinical Guidance; (4)
Nitrosamine Impurities in Rifamycins;
and (5) Electronic Directly Observed
Therapy (eDOT). Agenda items are
subject to change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–24505 Filed 11–4–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Center
for Preparedness and Response (BSC,
CPR); Correction
The meeting time, matters to be
considered and contact information
should read as follows:
The webinar meeting will be
held on October 26, 2020, from 12:30
p.m. to 1:30 p.m., EDT.
DATES:
SUPPLEMENTARY INFORMATION:
Purpose: This Board is charged with
providing advice and guidance to the
Secretary, Department of Health and
Human Services (HHS), the Assistant
Secretary for Health (ASH), the Director,
Centers for Disease Control and
Prevention (CDC), and the Director,
Center for Preparedness and Response
(CPR), concerning strategies and goals
for the programs and research within
CPR, monitoring the overall strategic
direction and focus of the CPR Divisions
and Offices, and administration and
oversight of peer review for CPR
scientific programs. For additional
information about the Board, please
visit: https://www.cdc.gov/cpr/bsc/
index.htm.
Matters to be Considered: The agenda
will include: (1) CPR Updates from the
Director; and (2) BSC, CPR Polio
Containment Workgroup (PCWG)
Update.
FOR FURTHER INFORMATION CONTACT:
Dometa Ouisley, Office of Science and
Public Health Practice, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, Mailstop H21–6,
Atlanta, Georgia 30329, Telephone:
(404) 639–7450; Email:
OPHPR.BSC.Questions@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives
Unit,Office of the Chief Operating
Officer,Centers for Disease Control and
Prevention.
khammond on DSKJM1Z7X2PROD with NOTICES
[FR Doc. 2020–24506 Filed 11–4–20; 8:45 am]
Notice is hereby given of a change in
the meeting of the Board of Scientific
Counselors, Center for Preparedness and
Response (BSC, CPR); October 26, 2020,
12:30 p.m. to 3:30 p.m., EDT; which was
published in the Federal Register on
September 14, 2020 Volume 85, Number
178, page 56618.
VerDate Sep<11>2014
20:36 Nov 04, 2020
Jkt 253001
BILLING CODE 4163–18–P
PO 00000
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Lead Exposure and Prevention
Advisory Committee (LEPAC);
Correction
Notice is hereby given of a change in
the date for the solicitation of
nominations for appointment to the
Lead Exposure and Prevention Advisory
Committee (LEPAC); December 15, 2021
which was published in the Federal
Register on October 28, 2020 Volume
85, Number 209, pages 68328–68329.
The notice should read as follows:
DATES: Nominations for membership on
the LEPAC must be received no later
than November 27, 2020. Packages
received after this time will not be
considered for the current membership
cycle.
ADDRESSES: All nominations should be
emailed to LEPAC@cdc.gov.
FOR FURTHER INFORMATION CONTACT: Ms.
Perri Ruckart, M.P.H., Designated
Federal Officer, National Center for
Environmental Health, CDC, 4770
Buford Highway, Atlanta, GA 30341,
770–488–3300, PRuckart@cdc.gov.
SUPPLEMENTARY INFORMATION: The
Director, Strategic Business Initiatives
Unit, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention, has been delegated the
authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–24507 Filed 11–4–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
Frm 00055
Fmt 4703
Sfmt 4703
E:\FR\FM\05NON1.SGM
05NON1
]]>Agencies
[Federal Register Volume 85, Number 215 (Thursday, November 5, 2020)]
[Notices]
[Page 70630]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-24507]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Lead Exposure and Prevention Advisory Committee (LEPAC);
Correction
Notice is hereby given of a change in the date for the solicitation
of nominations for appointment to the Lead Exposure and Prevention
Advisory Committee (LEPAC); December 15, 2021 which was published in
the Federal Register on October 28, 2020 Volume 85, Number 209, pages
68328-68329.
The notice should read as follows:
DATES: Nominations for membership on the LEPAC must be received no
later than November 27, 2020. Packages received after this time will
not be considered for the current membership cycle.
ADDRESSES: All nominations should be emailed to [email protected].
FOR FURTHER INFORMATION CONTACT: Ms. Perri Ruckart, M.P.H., Designated
Federal Officer, National Center for Environmental Health, CDC, 4770
Buford Highway, Atlanta, GA 30341, 770-488-3300, [email protected].
SUPPLEMENTARY INFORMATION: The Director, Strategic Business Initiatives
Unit, Office of the Chief Operating Officer, Centers for Disease
Control and Prevention, has been delegated the authority to sign
Federal Register notices pertaining to announcements of meetings and
other committee management activities, for both the Centers for Disease
Control and Prevention and the Agency for Toxic Substances and Disease
Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-24507 Filed 11-4-20; 8:45 am]
BILLING CODE 4163-18-P
